SEC Comment Letter 0000000000-24-012797 to Clene Inc. (CLNN)
Clene Inc.
Date: Nov. 19, 2024 · CIK: 0001822791 · Accession: 0000000000-24-012797
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-283204
Letter
November 19, 2024 Robert Etherington Chief Executive Officer Clene Inc. 6550 South Millrock Drive, Suite G50 Salt Lake City, UT 84121 Re:Clene Inc. Registration Statement on Form S-3 Filed November 13, 2024 File No. 333-283204 Dear Robert Etherington: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Lauren Hamill at 303-844-1008 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Tom McAleavey
Show Raw Text
November 19, 2024
Robert Etherington
Chief Executive Officer
Clene Inc.
6550 South Millrock Drive, Suite G50
Salt Lake City, UT 84121
Re:Clene Inc.
Registration Statement on Form S-3
Filed November 13, 2024
File No. 333-283204
Dear Robert Etherington:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Lauren Hamill at 303-844-1008 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Tom McAleavey